Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 3:01 pm Sale | 13G | ICONIX BRAND GROUP INC. ICON | Mudrick Capital Management L.P. | 0 0% | -1,401,749 (Position Closed) | View |
| 2021-08-06 4:06 pm Purchase | 13G | ICONIX BRAND GROUP, INC N ICON | Beryl Capital Management LLC | 917,057 6.3% | 917,057 (New Position) | View |
| 2021-06-25 5:17 pm Purchase | 13D | ICONIX BRAND GROUP, INC N ICON | Iconix Acquisition LLC | 6,185,111 30.8% | 6,185,111 (New Position) | View |
| 2021-02-12 4:35 pm Purchase | 13G | ICONIX BRAND GROUP INC. ICON | Mudrick Capital Management L.P. | 1,401,749 9.985% | 217,594 (+18.38%) | View |
| 2021-02-12 09:47 am Unchanged | 13G | UBS GROUP AG UBS | UBS ASSET MANAGEMENT AMERICAS INC | 0 0% | 0 (Unchanged) | View |
| 2020-05-21 5:07 pm Purchase | 13G | ICONIX BRAND GROUP INC. ICON | Mudrick Capital Management L.P. | 1,184,155 9.985% | 1,184,155 (New Position) | View |
| 2020-02-14 1:21 pm Sale | 13G | ICONIX BRAND GROUP, INC. ICON | Radcliffe Capital Management L.P. | 0 0% | -7,708,845 (Position Closed) | View |
| 2020-02-12 10:02 am Sale | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | UBS ASSET MANAGEMENT AMERICAS INC | 616,908 5% | -187,891 (-23.35%) | View |
| 2019-06-07 5:18 pm Unchanged | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | UBS ASSET MANAGEMENT AMERICAS INC | 804,799 6.95% | 0 (Unchanged) | View |
| 2019-06-07 2:34 pm Sale | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | UBS ASSET MANAGEMENT AMERICAS INC | 804,799 6.95% | -183,390 (-18.56%) | View |